Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Pietrantonio

Showing results (21-30 of 323) with videos related to

Pageof 33
Sort By:
Drugs & Aging|December 16, 2010
Role of the antiangiogenic agent bevacizumab in the treatment of elderly patients with metastatic colorectal cancerMaria Di Bartolomeo, Filippo Pietrantonio, Antonia Martinetti, et al.
Cancer Discovery|November 23, 2016
Targeting Cancer Metabolism: Dietary and Pharmacologic InterventionsClaudio Vernieri, Stefano Casola, Marco Foiani, et al.
Tumori|March 11, 2011
An unusually large pleural mesothelioma with an outstanding clinical response and long lasting survival: a case report and literature reviewNicoletta Zilembo, Milena Vitali, Filippo Pietrantonio, et al.
Pharmacogenomics|July 26, 2018
Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategiesAlessandra Raimondi, Federico Nichetti, Giorgia Peverelli, et al.
Annals of Surgical Oncology|June 29, 2016
Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative StudyDario Baratti, Shigeki Kusamura, Massimo Milione, et al.
Cancer Treatment Reviews|December 11, 2019
Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancerFilippo Pietrantonio, Giovanni Randon, Dario Romagnoli, et al.
Expert Review of Molecular Diagnostics|February 13, 2018
Bright-field in situ hybridization detects gene alterations and viral infections useful for personalized management of cancer patientsChiara C Volpi, Ambra V Gualeni, Filippo Pietrantonio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2025
Targeting the MAP kinase pathway in colorectal cancer: A journey in personalized medicineJordan W Appleyard, Christopher J M Williams, Paolo Manca, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 25, 2021
No benefit after neoadjuvant chemoradiation in stage IV rectal cancer: A propensity score-matched analysis on a real-world populationPamela Milito, Luca Sorrentino, Filippo Pietrantonio, et al.
The Oncologist|June 4, 2026
Rarity Within Rarity: Complete Response to Chemoimmunotherapy in a Patient with Polymerase epsilon (POLE)-Mutated locally advanced Jejunal CarcinomaMichele Prisciandaro, Federica Morano, Davide Citterio, et al.
Pageof 33

Showing results (21-30 of 323) with videos related to

Sort By:
Pageof 33
Drugs & Aging|December 16, 2010
Role of the antiangiogenic agent bevacizumab in the treatment of elderly patients with metastatic colorectal cancerMaria Di Bartolomeo, Filippo Pietrantonio, Antonia Martinetti, et al.
Cancer Discovery|November 23, 2016
Targeting Cancer Metabolism: Dietary and Pharmacologic InterventionsClaudio Vernieri, Stefano Casola, Marco Foiani, et al.
Tumori|March 11, 2011
An unusually large pleural mesothelioma with an outstanding clinical response and long lasting survival: a case report and literature reviewNicoletta Zilembo, Milena Vitali, Filippo Pietrantonio, et al.
Pharmacogenomics|July 26, 2018
Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategiesAlessandra Raimondi, Federico Nichetti, Giorgia Peverelli, et al.
Annals of Surgical Oncology|June 29, 2016
Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative StudyDario Baratti, Shigeki Kusamura, Massimo Milione, et al.
Cancer Treatment Reviews|December 11, 2019
Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancerFilippo Pietrantonio, Giovanni Randon, Dario Romagnoli, et al.
Expert Review of Molecular Diagnostics|February 13, 2018
Bright-field in situ hybridization detects gene alterations and viral infections useful for personalized management of cancer patientsChiara C Volpi, Ambra V Gualeni, Filippo Pietrantonio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2025
Targeting the MAP kinase pathway in colorectal cancer: A journey in personalized medicineJordan W Appleyard, Christopher J M Williams, Paolo Manca, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 25, 2021
No benefit after neoadjuvant chemoradiation in stage IV rectal cancer: A propensity score-matched analysis on a real-world populationPamela Milito, Luca Sorrentino, Filippo Pietrantonio, et al.
The Oncologist|June 4, 2026
Rarity Within Rarity: Complete Response to Chemoimmunotherapy in a Patient with Polymerase epsilon (POLE)-Mutated locally advanced Jejunal CarcinomaMichele Prisciandaro, Federica Morano, Davide Citterio, et al.
Pageof 33